title: Epidemiology of diabetes mellitus in Mexico.
abstract: Type 2 diabetes is the main health problem in Mexico. The large and growing number of cases and the remarkable economic impact of the disease support this statement. The condition is expressed at an earlier age and at a lower body mass index in Mexican mestizos compared with the age and body mass index reported in Caucasians. In addition, Mexican mestizos have an increased susceptibility to developing diabetic nephropathy. The Mexican health system needs major adjustments in order to prevent and treat type 2 diabetes. Treatment is not currently based on the needs and expectations of the patient. As a result, it is insufficient, belated, and costly. Close to 20% of the preventable deaths in Mexico are caused by diabetes and related metabolic diseases. Even a small decrease in this rate could result in substantial savings for the Mexican healthcare system.
authors.affiliation: R. Rojas-Martinez and M. Hernández-Avila are with the Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico. O.Y. Bello-Chavolla and C.A. Aguilar-Salinas are with the Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. O.Y. Bello-Chavolla is also the Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
authors.forename: Omar Y
authors.initials: OY
authors.lastname: Bello-Chavolla
authors.affiliation: R. Rojas-Martinez and M. Hernández-Avila are with the Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico. O.Y. Bello-Chavolla and C.A. Aguilar-Salinas are with the Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. O.Y. Bello-Chavolla is also the Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
authors.forename: Rosalba
authors.initials: R
authors.lastname: Rojas-Martinez
authors.affiliation: R. Rojas-Martinez and M. Hernández-Avila are with the Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico. O.Y. Bello-Chavolla and C.A. Aguilar-Salinas are with the Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. O.Y. Bello-Chavolla is also the Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico. carlos.aguilars@incmnsz.mx.
authors.forename: Carlos A
authors.initials: CA
authors.lastname: Aguilar-Salinas
authors.affiliation: R. Rojas-Martinez and M. Hernández-Avila are with the Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico. O.Y. Bello-Chavolla and C.A. Aguilar-Salinas are with the Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. O.Y. Bello-Chavolla is also the Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
authors.forename: Mauricio
authors.initials: M
authors.lastname: Hernández-Avila
mesh_terms: D002908:Chronic Disease; D003924:Diabetes Mellitus, Type 2 / Q000191:economics / Q000453:epidemiology* / Q000628:therapy; D006801:Humans; D008800:Mexico / Q000453:epidemiology; D009749:Nutrition Surveys; D015995:Prevalence; D012959:Socioeconomic Factors
keywords: Mexican population; diabetes mellitus; epidemiology; healthcare system; prevention and control